Market Capitalization (Millions $) |
274 |
Shares
Outstanding (Millions) |
343 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-51 |
Cash Flow (TTM) (Millions $) |
90 |
Capital Exp. (TTM) (Millions $) |
0 |
Aslan Pharmaceuticals Limited
Aslan Pharmaceuticals Limited is a biopharmaceutical company that focuses on the development of innovative therapeutics for oncology and immunology. They utilize precision medicine approaches to develop targeted therapies for patients with unmet medical needs. Aslan Pharmaceuticals has a diverse pipeline of drug candidates, including both small molecule and antibody therapies. They collaborate with leading academic institutions and research organizations to advance their drug development programs.
Company Address: 3 Temasek Avenue Level 18 Centennial Tower Singapore 39190
Company Phone Number: 6817 9598 Stock Exchange / Ticker: NASDAQ ASLN
ASLN is expected to report next financial results on March 23, 2024. |
|
|